
usd jan pm et
summari develop make distribut product servic companion anim
veterinari livestock poultri water test dairi market global
price-to-earnings oper ep
see demand product servic
remain strong pet ownership increas global
consum spend pet-rel servic
could lose market share competitor face
increas price pressur think
maintain net debt ebitda
ratio recent year
concern macroeconom downturn think
could pressur given product
servic tie discretionari consum spend
fiscal year end dec ep estim base cfra
oper earn histor earn report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
inc lower
target price base
above-p forward price-to-earnings ratio vs idxx
rang
ep estim
trade peer due resili
oper model attract growth
opportun ep vs
higher consensu expect
howev quarter result benefit
higher share-bas
compens activ lower
ceo transit charg expect
final tax interest
estim keep ep estim
initi ep
sale grew yoy million
recur revenu grew yoy
million dont anticip coronaviru
materi impact idxx result sinc
china make less total
revenu keep sell rate base
valuat downsid risk /kevin huang
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview inc togeth subsidiari develop manufactur
distribut product servic primarili companion anim veterinari livestock poultri
water test dairi market world-wide compani provid point-of-car veterinari diagnost
product includ instrument consum rapid assay veterinari refer laboratori
diagnost consult servic practic manag system servic digit imag
system veterinarian biolog materi test laboratori anim diagnost instrument
servic biomed research commun also offer diagnost health-monitor food
safeti test product livestock poultri dairi market product test water variou
microbiolog contamin point-of-car electrolyt blood ga analyz use
oper three primari busi segment companion anim group water qualiti
product livestock poultri dairi oper segment contain busi
meet quantit threshold report segment
companion anim group total sale provid veterinarian diagnost capabl
inform manag solut enhanc health well-b pet diagnost
provid diagnost capabl meet veterinarian divers need varieti modal
includ in-clin diagnost solut outsid refer laboratori servic in-clin diagnost
solut compris vetlab suit in-clin chemistri hematolog immunoassay
urinalysi coagul analyz associ proprietari consum product provid real-tim
refer lab qualiti diagnost result broad rang single-us handheld snap rapid assay
test kit provid quick accur conveni point-of-car diagnost test result varieti
companion anim diseas health condit offer commerci refer laboratori diagnost
consult servic veterinarian world-wide compani refer laboratori offer larg
select test diagnost panel detect number diseas state condit
anim includ test run in-clin veterinari practic instrument rapid
assay diagnost imag system captur radiograph imag digit form replac
tradit x-ray film film develop process gener requir use hazard
chemic darkroom
water qualiti product segment provid innov test solut easi rapid
accur detect quantif variou microbiolog paramet water princip
product colilert colisur test simultan detect presenc total
coliform coli water compani water test use govern laboratori water
util privat certifi laboratori test drink water complianc regulatori standard
includ environment protect agenc standard test also use evalu water
use product process exampl beverag pharmaceut applic
evalu bottl water recreat water wastewat water privat well
livestock poultri dairi segment sell diagnost test servic relat instrument
use manag health statu livestock poultri improv bovin reproduct
effici ensur qualiti safeti milk food livestock poultri diagnost
product purchas govern privat laboratori provid test servic livestock
veterinarian produc processor princip livestock poultri diagnost product includ
test bovin viral diarrhea viru porcin reproduct respiratori syndrom
segment sell point-of-car analyz relat consum use human medic
hospit clinic measur electrolyt blood gase acid-bas balanc glucos lactat blood urea
nitrogen ioniz calcium calcul paramet base excess anion gap
opti analyz use primarili emerg room oper room cardiac monitor area
locat time-crit diagnost test perform within hospit set
market profil compet mani compani rang larg human pharmaceut
medic diagnost compani small busi focus anim health companion anim
group primari north american competitor includ antech diagnost unit vca inc abaxi inc
heska corpor zoeti inc electrolyt blood ga analyz market compet
primarili larg human medic diagnost compani radiomet a/ siemen medic
solut diagnost instrument laboratori compani abbott diagnost divis abbott
laboratori roch diagnost corpor
financi experienc revenu growth billion follow growth
five-year compound annual growth rate compound-annual-growth-rate revenu high
net debt total capit ratio septemb allevi concern around
idxx leverag net debt trailing-twelve-month ebitda consist free cash flow
gener gener million slightli million
world-wide oper
senior director
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued usd
bullish sinc januari technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
next month neutral expect
compani continu achiev robust organ
growth mid- high-single-digit revenu
growth driven new product
data provid estim world-wide medic
devic sale grow
time think potenti slowdown
macroeconom growth could pressur
industri driver yet sub-industri
includ mani product area
histor recession-resist
equip use non-elect procedur
gener see posit long-term
fundament medic devic manufactur
includ increas global demand
popul rise outlay
result steadi flow innov product
revenu growth
polit regulatori perspect
medic devic industri larg avoid
scrutini unlik area health
drug maker fact medic devic tax
final repeal decemb remov
signific risk sale devic maker
think industri continu
dwindl industri come back
favor especi sinc valuat health
rel
forward price-to-earn basi think
higher valuat sub-industri
mostli warrant margin expans
revenu growth opportun associ
 medic devic regul
mdr go effect may
follow vitro devic
regul ivdr goe effect
devic compani made much
commentari around introduct mdr
reason believ new
regul could neg impact
industri exampl juli
submit letter world trade
organ request mdr ivdr
delay three year also novemb
associ critic slow piecem
implement new regulatori
accord evalu
billion valu prior
five-year averag deal total
billion industri debt level measur
net debt rel total capit appear
declin substanti follow
sever year increas think
industri could see increas deal
especi new ceo sever
major firm
expect industri earn rise
low-double-digit percentag driven sale
new product command higher
margin project industri oper
ebit margin
estim margin
 health equip
valu composit index
 health equip
sub-index rose vs declin
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
pm et cfra keep hold opinion share inc
rais target base
above-p ratio ep estim multipl
slightli averag reflect attract growth opportun
robust recur revenu ep vs exce consensu
expect rais ep estim sale
increas yoy organ million driven companion anim
group diagnost recur revenu growth organ growth
diagnost recur revenu primarili driven volum growth aid
net price realiz addit catalyst analyz instal
base grew yoy achiev better-than-expect oper margin
basi point higher prior-year period due gross
margin gain oper leverag lift full-year ep expect
reflect oper margin improv /kevin huang cfa
pm et cfra maintain hold opinion share
inc rais target above-p
ep estim think multipl appropri given
attract growth opportun robust recur revenu ep
vs higher estim lower ep
estim initi ep estim
revenu increas yoy organ million companion anim
group segment sale led way yoy growth revenu
organ sale continu benefit expand premium
instrument base benefit new test innov refer laboratori
diagnost consult servic also saw robust growth quarter
organ sale growth yoy sale total continu
domin growth increas yoy versu growth intern sale
despit attract growth opportun think share current
analyst research note compani news
pm et cfra keep sell opinion share inc
lower target price base
above-p forward price-to-earnings ratio vs idxx rang
ep estim trade peer due
resili oper model attract growth opportun ep
vs higher consensu expect howev
quarter result benefit higher share-bas
compens activ lower ceo transit charg
expect final tax interest estim keep
ep estim initi ep
sale grew yoy million companion anim group diagnost
recur revenu grew yoy million dont anticip
coronaviru materi impact idxx result sinc china make
less total revenu keep sell rate base valuat
downsid risk /kevin huang cfa
pm et cfra maintain sell opinion share
inc lift target base
above-p forward price-to-earnings ratio averag
ep estim trade peer due resili oper
model attract growth opportun ep vs exceed
estim primarili stronger-than-expect oper
margin lower ep estim maintain
ep sale grew yoy organ million ahead
expect quarter out-performance mostli attribut
companion anim group recur revenu growth
organ prior two quarter lower ep
guidanc reflect neg impact relat ceo transit
charg also provid preliminari outlook
organ revenu growth ep growth fall in-lin
pm et cfra reiter sell opinion share
inc rais target base
above-p forward price-to-earnings ratio averag
ep estim trade peer due attract growth
opportun robust recur revenu lift ep estim
ep ep vs
beat expect primarili
stronger-than-expect oper margin reflect gross margin gain
better-than-expect oper leverag sale increas yoy
organ million slightli short expect diagnost
recur revenu grew yoy organ net estim headwind
relat brexit expect lower revenu growth
stronger-than-expect currenc headwind disrupt oper
refin howev anticip higher full-year oper margin
growth off-set impact weaker revenu growth /kevin huang cfa
pm et cfra lower opinion share
sell hold lower opinion share
find trade expens valuat recent
think recent share valuat fulli reflect risk relat
potenti slowdown macroeconom growth share
significantli outperform industri peer out-perform
reflect expens forward price-to-earnings ratio compani
five-year averag despit consensu expect slowdown ep
growth end achiev ep compound annual growth rate
compound-annual-growth-rate expect ep compound-annual-growth-rate
avoid fallout headlin around human health
care cost compani avoid concern slow macroeconom growth
think could experi sever multipl compress
macroeconom growth slow pet owner gener pay cash pocket
veterinari servic /kevin huang cfa
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
